168 related articles for article (PubMed ID: 34694452)
1. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.
Benoit C; Rodrigues A; Calderaro J; Charpy C; Simonin S; Deybach JC; Gouya L; Puy H; Schmitt C; Farcy R; Vilgrain V; Paradis V; Pote N; Lafdil F; Mule S; Itti E; Luciani A
Eur Radiol; 2022 Apr; 32(4):2481-2491. PubMed ID: 34694452
[TBL] [Abstract][Full Text] [Related]
2. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
3. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.
Heide R; Strobel D; Bernatik T; Goertz RS
Ultraschall Med; 2010 Aug; 31(4):405-9. PubMed ID: 20652853
[TBL] [Abstract][Full Text] [Related]
5. Characterization of focal liver masses using acoustic radiation force impulse elastography.
Park H; Park JY; Kim DY; Ahn SH; Chon CY; Han KH; Kim SU
World J Gastroenterol; 2013 Jan; 19(2):219-26. PubMed ID: 23345944
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma.
Komine F; Shimojima M; Moriyama M; Amaki S; Uchida T; Arakawa Y
J Hepatol; 2000 Feb; 32(2):235-41. PubMed ID: 10707863
[TBL] [Abstract][Full Text] [Related]
8. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
[TBL] [Abstract][Full Text] [Related]
9. Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy.
Cartier V; Crouan A; Esvan M; Oberti F; Michalak S; Gallix B; Seror O; Paisant A; Vilgrain V; Aubé C;
Diagn Interv Imaging; 2018; 99(7-8):493-499. PubMed ID: 29501461
[TBL] [Abstract][Full Text] [Related]
10. [Radiological diagnostic workup of liver tumors].
Raatschen HJ
Internist (Berl); 2020 Feb; 61(2):123-130. PubMed ID: 31919534
[TBL] [Abstract][Full Text] [Related]
11. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.
Chen ZG; Xu L; Zhang SW; Huang Y; Pan RH
World J Gastroenterol; 2015 Feb; 21(5):1621-7. PubMed ID: 25663782
[TBL] [Abstract][Full Text] [Related]
12. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
Furuta T; Kanematsu T; Sonoda T; Sugimachi K
Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.
Wee A
Cytopathology; 2011 Oct; 22(5):287-305. PubMed ID: 21762411
[TBL] [Abstract][Full Text] [Related]
14. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver.
Tajima T; Honda H; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Taguchi K; Shimada M; Masuda K
J Comput Assist Tomogr; 1999; 23(5):690-5. PubMed ID: 10524847
[TBL] [Abstract][Full Text] [Related]
15. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
17. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
[TBL] [Abstract][Full Text] [Related]
18. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients.
Bennett GL; Krinsky GA; Abitbol RJ; Kim SY; Theise ND; Teperman LW
AJR Am J Roentgenol; 2002 Jul; 179(1):75-80. PubMed ID: 12076908
[TBL] [Abstract][Full Text] [Related]
19. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
Galia M; Taibbi A; Marin D; Furlan A; Dioguardi Burgio M; Agnello F; Cabibbo G; Van Beers BE; Bartolotta TV; Midiri M; Lagalla R; Brancatelli G
Diagn Interv Radiol; 2014; 20(3):222-8. PubMed ID: 24509186
[TBL] [Abstract][Full Text] [Related]
20. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
